Disopyramide phosphate: clinical efficacy of a new oral antiarrhythmic drug.
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001581:Benzothiadiazines; D004077:Digoxin / Q000627:therapeutic use; D004206:Disopyramide / Q000627:therapeutic use; D004232:Diuretics; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D010919:Placebos; D011189:Potassium Chloride / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use*; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D001581:Benzothiadiazines; D004232:Diuretics; D010919:Placebos; D011725:Pyridines; D049993:Sodium Chloride Symporter Inhibitors; D008750:Methyldopa; D011189:Potassium Chloride; D004077:Digoxin; D004206:Disopyramide